0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE
William D. Figg, PharmD, MBA; Ian M. Thompson, MD
JAMA Oncol. 2015;1(3):321-322. doi:10.1001/jamaoncol.2015.0408.

JAMA Oncology | 
Original Investigation |  FREE
Laurent Azoulay, PhD; Maria Eberg, MSc; Serge Benayoun, MD, MSc; et al.
JAMA Oncol. 2015;1(3):314-320. doi:10.1001/jamaoncol.2015.0387.
Includes: Supplemental Content

JAMA Dermatology | 
Editorial | 
Thomas J. Moore, AB
JAMA Dermatol. 2015;151(6):585-586. doi:10.1001/jamadermatol.2015.37.

JAMA | 
JAMA Revisited | 
A. H. Wilson, M.D., M.R.C.S.
JAMA. 2014;312(5):562. doi:10.1001/jama.2013.279650.

JAMA | 
The Rational Clinical Examination | 
Karen A. D’Silva, MD, MS; Philipp Dahm, MD, MHSc; Camilla L. Wong, MD, MHSc
JAMA. 2014;312(5):535-542. doi:10.1001/jama.2014.5555.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Mark A. Preston, MD, MPH; Kathryn M. Wilson, ScD; Sarah C. Markt, MPH, ScD; et al.
JAMA Intern Med. 2014;174(8):1301-1307. doi:10.1001/jamainternmed.2014.1600.

JAMA | 
JAMA Patient Page |  FREE
Ryszard M. Pluta, MD, PhD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2012;307(5):527. doi:10.1001/jama.2011.2008.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letters |  FREE
Melanie C. Wuerstle, MD; Stephen K. Van Den Eeden, PhD; K. Trudy Poon, MS; et al.
Arch Intern Med. 2011;171(18):1680-1682. doi:10.1001/archinternmed.2011.475.

JAMA | 
Original Contribution |  FREE
Michael J. Barry, MD; Sreelatha Meleth, PhD; Jeannette Y. Lee, PhD; et al.
JAMA. 2011;306(12):1344-1351. doi:10.1001/jama.2011.1364.
Includes: Supplemental Content

JAMA | 
Clinical Review |  FREE
Thunyarat Anothaisintawee, MD; John Attia, MD, PhD, FRCPC; J. Curtis Nickel, MD, FRCSC; et al.
JAMA. 2011;305(1):78-86. doi:10.1001/jama.2010.1913.
Includes: CME, Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Editorial  | 
Finasteride and the Uncertainties of Establishing Harms
Thomas J. Moore, AB
JAMA Oncology
Invited Commentary  | 
Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer
William D. Figg, PharmD, MBA; Ian M. Thompson, MD
JAMA Oncology
Original Investigation  | 
5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
Laurent Azoulay, PhD; Maria Eberg, MSc; Serge Benayoun, MD, MSc; et al.
JAMA
JAMA Revisited  | 
The Prostate Gland: A Review of its Anatomy, Pathology, and Treatment
A. H. Wilson, M.D., M.R.C.S.